FOLR2 and neoplasm: For instance, chimeric antigen receptor (CAR)-T cells engineered to recognise folate receptor beta (FRβ), a marker enriched on immunosuppressive TAMs, successfully deplete this population, promote pro-inflammatory polarisation, and suppress tumour growth in preclinical models (154).